Mar 2, 2024, 12:40
David James Pinato: Immunotherapy is truly changing the way we treat HCC
David James Pinato, Director of Developmental Cancer Therapeutics, Clinical Senior Lecturer and Consultant Medical Oncologist at Imperial College London, recently shared on LinkedIn:
“Immunotherapy is truly changing the way we treat HCC. Honoured to have been asked to make sense of this for Nature Medicine with Antonio D’Alessio and Claudia Angela Maria Fulgenzi”
Source: David James Pinato/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33
Dec 21, 2024, 13:20
Dec 21, 2024, 13:12
Dec 21, 2024, 13:05
Dec 21, 2024, 12:18